Chuanyuan Kang

620 citations
30 papers · 332 indexed · h-index 12
Topics
Attention Deficit Hyperactivity Disorder (7 papers)COVID-19 and Mental Health (5 papers)Bipolar Disorder and Treatment (4 papers)

In The Last Decade

Chuanyuan Kang

28 papers receiving 328 citations

Peers

Chuanyuan Kang
Comparison fields: 5 of 59
  • Psychiatry and Mental health 126
  • Clinical Psychology 99
  • Cognitive Neuroscience 92
  • Genetics 44
  • Molecular Biology 40
Replace Ümit Işık with:
Ümit Işık Türkiye
Agnieszka Gmitrowicz Poland
Carlos Martín Spain
Ömer Faruk Akça Türkiye
Liis Merenäkk Estonia
Major R. Bradshaw United States
Jozef Peuskens Belgium
Ali Bani‐Fatemi Canada
Linda A. Antonucci Italy
Lilliana Dell’Osso Italy
Chuanyuan Kang relative to Ümit Işık Türkiye Ümit Işık's profile →
Citations per field
00.5×1.5×
Ümit Işık · 1×
Citations per year

Countries citing papers authored by Chuanyuan Kang

Since Specialization
Citations

This map shows the geographic impact of Chuanyuan Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanyuan Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanyuan Kang more than expected).

Fields of papers citing papers by Chuanyuan Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanyuan Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanyuan Kang. The network helps show where Chuanyuan Kang may publish in the future.

Co-authorship network of co-authors of Chuanyuan Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanyuan Kang. A scholar is included among the top collaborators of Chuanyuan Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanyuan Kang. Chuanyuan Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 10
3 1
4 3
5 4
6 17
7 11
8 8
9 9
10 21
11 5
12 13
13 37
14 3
15 4
16 1
17 6
18 13
19 30
20 26

About Chuanyuan Kang

Chuanyuan Kang is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Clinical Psychology, having authored 30 papers that have together received 332 indexed citations. Recurring topics across this work include Attention Deficit Hyperactivity Disorder (7 papers), COVID-19 and Mental Health (5 papers) and Bipolar Disorder and Treatment (4 papers). The work is most often cited by research in Biological Psychiatry (27 citations), Psychiatry and Mental health (126 citations) and Cognitive Neuroscience (92 citations). Chuanyuan Kang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jianzhong Yang, Yujun Wei, Xu Li, Bing Wang, Xinxin Fan, Ruixiang Liu, Stephen V. Faraone, Rulun Zhou, Lili Guan and Xiufeng Xu. Their work appears in journals such as PLoS ONE, BMC Public Health and Psychoneuroendocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026